Vascular access type and risk of mortality in a national prospective cohort of haemodialysis patients
Authors:
- B. D. BrayBBB. D. Bray
- J. BoydJBJ. Boyd
- C. DalyCDC. Daly
- K. DonaldsonKDK. Donaldson
- A. DoyleADA. Doyle
- J. G. FoxJFJ. G. Fox
- A. InnesAIA. Innes
- I. KhanIKI. Khan
- R. K. PeelRPR. K. Peel
- A. SevernASA. Severn
- I. ShillidayISI. Shilliday
- K. SimpsonKSK. Simpson
Open Access
- 19 August 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 105 (11) , 1097-1103
Abstract
Background: Central venous catheters (CVC) are a potential source of bacteraemia and have been associated with increased mortality in haemodialysis patients. We aimed to investigate the relationships between haemodialysis vascular access, taking into account changes in vascular access type during patients’ lives, and cause specific mortality risk in a national cohort of dialysis patients. Methods: Prospective cohort study including all patients receiving haemodialysis in Scotland at annual cross sectional surveys in 2009, 2010 and 2011. Data were collected through the Scottish Renal Registry and by a structured review of case records following death. Cox proportional hazards regression and multivariable logistic regression were used to model survival and risk of death from septicaemia respectively. Results: Of a cohort of 2666 patients, 873 (32%) died during follow-up. After case-mix adjustment, patients using only tunnelled CVC during follow-up had a higher risk of all cause mortality across all strata of prior renal replacement therapy exposure [adjusted hazard ratio (HR): 1.83–2.08]. Case-mix adjusted risks of cardiovascular death (adjusted HR: 2.20–2.95) and infection-related death (adjusted HR: 3.10–3.63) were also higher in this group. Patients using tunnelled CVCs during follow-up and prior to death had 6.9-fold higher odds of death from septicaemia compared with those using only arteriovenous fistulae or grafts. Conclusions: Compared with an arteriovenous fistula or graft, sustained use of tunnelled CVCs for vascular access is associated with higher risks of all-cause, cardiovascular and infection-related mortality.Keywords
This publication has 18 references indexed in Scilit:
- Opinion: The Increasing Use of Hemodialysis Catheters: Evidence from the DOPPS on Its Significance and Ways to Reverse ItSeminars in Dialysis, 2010
- Facility Hemodialysis Vascular Access Use and Mortality in Countries Participating in DOPPS: An Instrumental Variable AnalysisAmerican Journal of Kidney Diseases, 2009
- Increased Hemodialysis Catheter Use in Canada and Associated Mortality RiskClinical Journal of the American Society of Nephrology, 2008
- Vascular access in haemodialysis patients: a modifiable risk factor for bacteraemia and deathQJM: An International Journal of Medicine, 2007
- Social deprivation and survival on renal replacement therapy in England and WalesKidney International, 2006
- Type of Vascular Access and Survival among Incident Hemodialysis PatientsJournal of the American Society of Nephrology, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- End-stage renal disease in Scotland: Outcomes and standards of careKidney International, 2003
- Vascular access and increased risk of death among hemodialysis patientsKidney International, 2002
- Type of vascular access and mortality in U.S. hemodialysis patientsKidney International, 2001